Christine Youn

Christine Youn

Auto-generated profile, based on publicly available information

Christine Youn

Department of Dermatology, Johns Hopkins University School of Medicine, 1550 Orleans Street, Baltimore, MD 21287, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
GPGarrett J. Patrick
Garrett J. Patrick
HLHaiyun Liu
Haiyun Liu
MAMartin P Alphonse
Martin P Alphonse
DDDustin A. Dikeman
Dustin A. Dikeman
CYChristine Youn
Christine Youn
LMLloyd S. Miller
Lloyd S. Miller
IgE induced by type 2 immune responses in atopic dermatitis is implicated in the progression of atopic dermatitis to other allergic diseases, including food allergies, allergic rhinitis, and asthma. However, the keratinocyte-derived signals that promote IgE and ensuing allergic diseases remain unclear. Herein, in a mouse model of atopic dermatitis–like skin inflammation induced by epicutaneous Staphylococcus aureus exposure, keratinocyte release of IL‑36α along with IL-4 triggered B cell IgE class-switching, plasma cell differentiation, and increased serum IgE levels—all of which were abrogated in IL-36R–deficient mice or anti-IL‑36R–blocking antibody–treated mice. Moreover, skin allergen sensitization during S. aureus epicutaneous exposure-induced IL-36 responses was required for the development of allergen-specific lung inflammation. In translating these findings, elevated IL‑36 cytokines in human atopic dermatitis skin and in IL‑36 receptor antagonist–deficiency patients coincided with increased serum IgE levels. Collectively, keratinocyte-initiated IL‑36 responses represent a key mechanism and potential therapeutic target against allergic diseases.

7 July 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MAMartin P Alphonse
Martin P Alphonse
JRJessica H. Rubens
Jessica H. Rubens
RORoger V. Ortines
Roger V. Ortines
NONicholas A. Orlando
Nicholas A. Orlando
APAman M. Patel
Aman M. Patel
LMLloyd S. Miller
Lloyd S. Miller
A pan-caspase inhibitor, Q-VD-OPH, has therapeutic efficacy against preclinical methicillin-resistant Staphylococcus aureus skin infection.

1 July 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
QDQuigly Dragotakes
Quigly Dragotakes
KSKaitlin M. Stouffer
Kaitlin M. Stouffer
MFMan Shun Fu
Man Shun Fu
YSYehonatan Sella
Yehonatan Sella
CYChristine Youn
Christine Youn
ACArturo Casadevall
Arturo Casadevall
Microbial ingestion by a macrophage results in the formation of an acidic phagolysosome but the host cell has no information on the pH susceptibility of the ingested organism. This poses a problem for the macrophage and raises the fundamental question of how the phagocytic cell optimizes the acidification process to prevail. We analyzed the dynamical distribution of phagolysosomal pH in murine and human macrophages that had ingested live or dead Cryptococcus neoformans cells, or inert beads. Phagolysosomal acidification produced a range of pH values that approximated normal distributions, but these differed from normality depending on ingested particle type. Analysis of the increments of pH reduction revealed no forbidden ordinal patterns, implying that the phagosomal acidification process was a stochastic dynamical system. Using simulation modeling, we determined that by stochastically acidifying a phagolysosome to a pH within the observed distribution, macrophages sacrificed a small amount of overall fitness to gain the benefit of reduced variation in fitness. Hence, chance in the final phagosomal pH introduces unpredictability to the outcome of the macrophage-microbe, which implies a bet-hedging strategy that benefits the macrophage. While bet hedging is common in biological systems at the organism level, our results show its use at the organelle and cellular level.

7 October 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ARAdvaitaa Ravipati
Advaitaa Ravipati
SNSabrina Nolan
Sabrina Nolan
MAMartin P Alphonse
Martin P Alphonse
DDDustin Dikeman
Dustin Dikeman
CYChristine Youn
Christine Youn
NANathan Archer
Nathan Archer

16 June 2023 in Science Advances
Verified
Journal Article
Open access
CYChristine Youn
Christine Youn
CPCristina Pontaza
Cristina Pontaza
YWYu Wang
Yu Wang
DDDustin A. Dikeman
Dustin A. Dikeman
DJDaniel P. Joyce
Daniel P. Joyce
NANathan Archer
Nathan Archer
Staphylococcus aureus is the leading cause of skin and soft tissue infections and is a major health burden due to the emergence of antibiotic-resistant strains. To address the unmet need of alternative treatments to antibiotics, a better understanding of the protective immune mechanisms against S. aureus skin infection is warranted. Here, we report that tumor necrosis factor (TNF) promoted protection against S. aureus in the skin, which was mediated by bone marrow–derived immune cells. Furthermore, neutrophil-intrinsic TNF receptor (TNFR) signaling directed immunity against S. aureus skin infections. Mechanistically, TNFR1 promoted neutrophil recruitment to the skin, whereas TNFR2 prevented systemic bacterial dissemination and directed neutrophil antimicrobial functions. Treatment with a TNFR2 agonist showed therapeutic efficacy against S. aureus and Pseudomonas aeruginosa skin infections, which involved increased neutrophil extracellular trap formation. Our findings revealed nonredundant roles for TNFR1 and TNFR2 in neutrophils for immunity against S. aureus and can be therapeutically targeted for protection against bacterial skin infections.

11 May 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CYChristine Youn
Christine Youn
NANathan Archer
Nathan Archer
LMLloyd S. Miller
Lloyd S. Miller